Current Assets: The sum of all assets that are classified as current, because they will provide a benefit within one year.
MiNK Therapeutics, Inc. (INKT) had Current Assets of $13.85M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-2.60M |
|
-- |
|
-- |
|
$2.71M |
|
$-2.71M |
|
$0.10M |
|
$-2.60M |
|
$-2.60M |
|
$-2.60M |
|
$-2.60M |
|
$-2.60M |
|
$-2.60M |
|
$-2.71M |
|
$-2.67M |
|
4.27M |
|
4.27M |
|
$-0.52 |
|
$-0.52 |
|
| Balance Sheet Financials | |
|
Current Assets |
$13.85M |
$0.39M |
|
$0.39M |
|
$14.24M |
|
$13.03M |
|
-- |
|
$15.44M |
|
$28.47M |
|
$-14.23M |
|
$-14.23M |
|
$-14.23M |
|
4.71M |
|
| Cash Flow Statement Financials | |
$-5.93M |
|
-- |
|
$14.72M |
|
$4.58M |
|
$13.36M |
|
$8.78M |
|
$2.67M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.06 |
|
-- |
|
-- |
|
-- |
|
-0.36 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.93M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
18.29% |
|
18.29% |
|
-18.27% |
|
18.29% |
|
$-3.02 |
|
$-1.39 |
|
$-1.39 |
|